:quality(80):format(png)/default_images/avatar_default.png){kind=avatar}
:quality(80):format(jpeg)/posts/2021-11/05/featured-e412c5818151a0d1c2f0f75a3c1367ea_1636097072-b.jpg)
:quality(80):format(jpeg)/entries/2021-11/05/29756-2-8d2fd1af275eafa1051ef8fa3345dd1d.jpg)
Inggris menjadi negara pertama di dunia yang akan memakai obat Molnupiravir untuk atasi Covid-19 (via cnn.com)
Dari hasil uji klinis menunjukkan bahwa orang paling efektif jika meminum selama tahap awal infeksi. MRHA menyarankan untuk mengkonsumsi obat ini dalam waktu 5 hari sejak munculnya gejala.
Ada beberapa orang yang cenderung memiliki setidak 1 faktor resiko pengembangan Covid-19 tingkat berat, seperti penderita obesitas, orang berusia lanjut, dan penderita penyakit jantung.
Saat ini, Inggris telah memesan sekitar 480.000 dosis Molnupiravir dari perusahaan farmasi raksasa AS, Merck.
Sementara itu, regulator obat Amerika Serikat dan Uni Eropa sedang mengevaluasi obat Mol Unipriavir.
:quality(80):format(jpeg)/posts/2024-04/26/featured-73764ca61c3ad51bf8d0645198fb1b63_1714095414-b.jpg)
:quality(80):format(jpeg)/members/avatar/anggun-septia-064cbf099420f5a54716c948c01be55d-s.jpg)
:quality(80):format(jpeg)/posts/2024-04/26/featured-959677a58fc4843fdc6e6c2fe2be832d_1714094800-b.jpg)
:quality(80):format(jpeg)/posts/2024-04/25/featured-12075f37a05470c9d0008cf2fa6ccfce_1714037961-b.jpg)
:quality(80):format(jpeg)/posts/2024-04/25/featured-7d675de5e226faf6d77f76bc3f82303a_1714026043-b.jpg)
:quality(80):format(jpeg)/posts/2024-04/25/featured-6ac21e760bf557fd02a6259f2fde2114_1714018660-b.jpg)
:quality(80):format(jpeg)/posts/2024-04/25/featured-bda82ca99d734b4381d77b46923aa523_1714018343-b.jpg)
:quality(80):format(jpeg)/posts/2024-04/24/featured-5a5b470df066a588d539941fa29c7cb6_1713967466-b.jpg)
:quality(80):format(jpeg)/posts/2024-04/24/featured-219017350f346499aebdacdcd5bf0602_1713966378-b.jpg)
:quality(80):format(jpeg)/members/avatar/riswinanti-permatasari-dc742d658ef092d6a4a6899e5601ace0-s.jpg)
:quality(80):format(jpeg)/posts/2024-04/24/featured-d14b1e52283049a575b938fa6c132f40_1713965466-b.jpg)
:quality(80):format(jpeg)/posts/2024-04/24/featured-dfebac7057f686a80019f825e4d9c7f2_1713948671-b.jpg)
:quality(80):format(jpeg)/posts/2024-04/24/featured-23ae8d7f819f6fb4fc62fd03b9d5c66d_1713948327-b.jpg)
:quality(80):format(jpeg)/posts/2024-04/24/featured-d40aa4e583f39c8acf602345eb7c64c5_1713941215-b.jpg)
:quality(80):format(jpeg)/posts/2024-04/24/featured-d14b1e52283049a575b938fa6c132f40_1713965466-b.jpg)
:quality(80):format(jpeg)/posts/2024-04/24/featured-219017350f346499aebdacdcd5bf0602_1713966378-b.jpg)
:quality(80):format(jpeg)/posts/2024-04/24/featured-6a3cfa9cc5cd1fcc7e0da134b3c42899_1713966928-b.jpg)
:quality(80):format(jpeg)/posts/2024-04/26/featured-da9bfed1a8fc9afe6aa2434498b942e6_1714095091-b.jpg)
:quality(80):format(jpeg)/posts/2024-04/26/featured-959677a58fc4843fdc6e6c2fe2be832d_1714094800-b.jpg)
:quality(80):format(jpeg)/posts/2024-04/25/featured-380b5fdfe90d8caad37f1a089405b0ac_1714052959-b.jpg)
:quality(80):format(jpeg)/posts/2024-04/20/featured-de295e70e8ef2b4f85d7188f6aa4a9e4_1713625943-b.jpg)
:quality(80):format(jpeg)/posts/2024-04/14/featured-9db0bd439e5cc9047e8fe206755914f6_1713052701-b.jpg)
:quality(80):format(jpeg)/posts/2024-04/02/featured-15acfc60aa38fd8993f960a4bcd87ea1_1712050164-b.jpg)
:quality(80):format(jpeg)/posts/2024-03/28/featured-ddbcd23165c96004ffae14cf9b16d2d0_1711635706-b.jpg)